PCME is an accredited provider specializing in innovative continuing medical education solutions.
PCME is an accredited provider specializing in innovative continuing medical education solutions.
Barry M. Massie, MD
Professor of Medicine
University of California, San Francisco
Chief, Cardiology Division
San Francisco VA Medical Center
San Francisco, CA
Barry M. Massie, MD is a Professor of Medicine at the University of California in San Francisco and Chief of the Cardiology Division at the San Francisco VAMC. He is a nationally and internationally recognized researcher and clinician in the fields of heart failure and hypertension. Dr. Massie was the Principal Investigator of the Warfarin and Antiplatelet Trial in Chronic Heart Failure (WATCH), a multicenter, multinational trial being conducted under the auspices of the VA Cooperative Study Program. He is also the Principal Investigator of the recently completed I-PRESERVE trial, the largest study of the treatment of patients with heart failure and preserved ejection fraction, and of the PROTECT Trial, which is evaluating the effects of adenosine-A1 receptor blockade in patients with acute decompensated heart failure. He serves as Principal Investigator or on the Executive Committee or DSMB for 10 other ongoing trials, including two major NHLBI studies. He is the Clinical Director of the VA Heart Failure Quality Enhancement Research Initiative of the Department of Veterans Affairs and has funded grants in the areas of health services and outcomes research. His Curriculum Vitae includes more than 260 peer-reviewed original publications.
In addition to his research and clinical work, Dr. Massie is a founding member of the Heart Failure Society of America (HFSA), and served as Program Chairman for the HFSA 2001 and 2002 annual scientific meetings. He has also served on the Program Committees of the American College of Cardiology and the European Society of Cardiology. He has been the Editor-in-Chief of the Journal of Cardiac Failure since 2000, as well as serving on the editorial boards of numerous other journals. He was a member of the Heart Failure Guideline Panel of the Agency for Health Care Policy and Research (now AHRQ) and has also served on the Guideline Committee of the Heart Failure Society. He consults regularly for the Food and Drug Administration Cardiorenal and Circulatory Device divisions, after serving as a member and Chairman of its Cardio-Renal Advisory Panel. Dr. Massie is currently the Vice-President and President-Elect of the HFSA
